| GC33684-100mg |
|
51-15-0 |
Pralidoxime chloride (2-PAM chloride)
|
0 |
C7H9ClN2O |
|
|
|
| GC33684-10mM(1mLinDMSO) |
|
51-15-0 |
Pralidoxime chloride (2-PAM chloride)
|
0 |
C7H9ClN2O |
|
|
|
| GC33683-5mg |
|
129198-88-5 |
Autocamtide 2 (Autocamtide II)
|
0 |
C65H118N22O20 |
|
|
|
| GC33683-1mg |
|
129198-88-5 |
Autocamtide 2 (Autocamtide II)
|
0 |
C65H118N22O20 |
|
|
|
| GC33682-100mg |
|
10510-54-0 |
|
0 |
C18H15N3O3 |
|
|
|
| GC33681-500mg |
|
87-44-5 |
β-Caryophyllene ((−)-trans-Caryophyllene)
|
0 |
C15H24 |
|
|
|
| GC33680-25mg |
|
159237-99-7 |
Phe-Met-Arg-Phe amide trifluoroacetate
|
0 |
C33H44F6N8O8S |
|
|
|
| GC33680-5mg |
|
159237-99-7 |
Phe-Met-Arg-Phe amide trifluoroacetate
|
0 |
C33H44F6N8O8S |
|
|
|
| GC33680-10mM(1mLinWater) |
|
159237-99-7 |
Phe-Met-Arg-Phe amide trifluoroacetate
|
0 |
C33H44F6N8O8S |
|
|
|
| GC33679-200mg |
|
166410-37-3 |
|
0 |
C21H26N2O2 |
|
|
|
| GC33679-10mM(1mLinDMSO) |
|
166410-37-3 |
|
0 |
C21H26N2O2 |
|
|
|
| GC33678-100mg |
|
92134-98-0 |
|
0 |
C16H13N2Na2O6P |
|
|
|
| GC33678-50mg |
|
92134-98-0 |
|
0 |
C16H13N2Na2O6P |
|
|
|
| GC33678-25mg |
|
92134-98-0 |
|
0 |
C16H13N2Na2O6P |
|
|
|
| GC33678-5mg |
|
92134-98-0 |
|
0 |
C16H13N2Na2O6P |
|
|
|
| GC33678-10mM(1mLinWater) |
|
92134-98-0 |
|
0 |
C16H13N2Na2O6P |
|
|
|
| GC33677-100mg |
|
305-33-9 |
|
0 |
C9H16N3O5P |
|
|
|
| GC33677-10mM(1mLinWater) |
|
305-33-9 |
|
0 |
C9H16N3O5P |
|
|
|
| GC33676-1g |
|
33996-33-7 |
Oxaceprol (N-Acetyl-L-hydroxyproline)
|
0 |
C7H11NO4 |
|
|
|
| GC33676-10mM(1mLinDMSO) |
|
33996-33-7 |
Oxaceprol (N-Acetyl-L-hydroxyproline)
|
0 |
C7H11NO4 |
|
|
|
